除細動器市場:製品タイプ別(植込み型除細動器、体外式除細動器)、患者タイプ別(成人、小児)、エンドユーザー別、地域別(北米、欧州、APAC、ラテンアメリカ、MEA) - 2026年までの世界予測Defibrillator Market by Product Type (Implantable Cardioverter Defibrillator and External Defibrillator), Patient Type (Adult, Pediatric), End Users, and Region(North America, Europe, APAC, Latin America & MEA) - Global Forecast to 2026 除細動器の世界市場は、2021年の114億米ドルから2026年には182億米ドルに達すると予測されており、2021年から2026年までの年平均成長率は9.7%となっています。 除細動器は、心臓のリズムを監視し、異常な心臓の... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー除細動器の世界市場は、2021年の114億米ドルから2026年には182億米ドルに達すると予測されており、2021年から2026年までの年平均成長率は9.7%となっています。除細動器は、心臓のリズムを監視し、異常な心臓のリズムを検出すると電気ショックを与えて修正する特殊な機器で、突然の心停止の治療に重要な役割を果たします。この市場の成長は、対象となる疾患の増加、公共の場での除細動器の提供、除細動器に関するトレーニングや啓蒙活動などが主な要因となっています。さらに、新興市場やS-ICD、MRI対応のICDやCRT-Dの開発が、除細動器市場のプレーヤーに成長機会を提供すると予想されます。心血管疾患(CVD)は、全世界で死亡や障害の主な原因となっています。世界では、2019年に1790万人のCVDによる死亡が報告されており、これは世界の総死亡数の32%に相当します(出典:WHO)。CVDによる死亡の75%以上は、低・中所得国で発生しています。米国だけでも、2018年には39万件以上の突然の心停止が発生しています(出典:米国心臓協会)。米国の全人口のうち、CVDによる死亡の約65%は75歳以上の高齢者、29%は55~74歳、6%は35~54歳の高齢者で発生しています。そのため、心停止の危険性が高い患者の命を救うために、除細動器の需要が高まっています。 しかし、植込み型および自動体外式除細動器の使用に関する問題、頻繁な製品リコール、発展途上国における突然の心停止に関する認識不足などが、予測期間中の除細動器市場の成長を妨げると予想されます。また、特に発展途上国や低開発国では、償還額が限られていることや、インフラが整備されていないことなども、この市場の成長を妨げる要因になると考えられます。 "2020年の世界の除細動器市場では、植込み型除細動器セグメントが最大のシェアを占めています" 除細動器市場は、タイプ別に植込み型除細動器(ICD)と体外式除細動器に大別されます。ICDはさらに、経静脈植え込み型除細動器と皮下植え込み型除細動器に分けられ、外部除細動器は手動AED、完全自動AED、ウェアラブル除細動器に分けられます。2020年の世界の除細動器市場では、ICDセグメントが71.5%のシェアを占めています。この市場セグメントのシェアが大きいのは、心血管疾患の有病率が増加していることと、技術的に高度な除細動器が開発されていることに起因すると考えられます。例えば2020年7月には、アボット社が「Gallant」のブランド名で次世代ICDとCRT-DのFDA承認を取得しました。 "2020年のエンドユーザーに基づく除細動器市場では、病院、診療所、心臓センターのセグメントが最大のシェアを占めている" 除細動器市場は、エンドユーザーに基づいて、病院、診療所、心臓センター、プレホスピタルケア設定、公共アクセス市場、代替ケア施設、在宅ケア設定、その他のエンドユーザーに分類されます。2020年には、病院、診療所、心臓センターのセグメントが80.2%のシェアを占め、世界の除細動器市場を席巻しました。先進的なICDおよびCRT-Dの開発と、病院、診療所、心臓センターで行われるICDおよびCRT-Dのインプラント手術の数が多いことが、このエンドユーザーセグメントの大きなシェアにつながっています。また、心臓移植の件数が増加していることや、先進国市場では償還が可能であることも、このエンドユーザーセグメントの成長を促進する主な要因です。米国心臓協会によると、米国だけでも毎月推定10,000件のICD処置が行われています(2016年7月時点のデータ)。同様に、イギリスにおけるICDインプラントの総数は、2012年の人口100万人あたり66件から、2014年には人口100万人あたり72件に増加しています(出典:British Heart Rhythm Society)。 "2020年の患者タイプ別除細動器市場では、成人患者セグメントが最大のシェアを占める" 患者タイプに基づいて、除細動器市場は成人患者と小児患者に分けられます。成人患者のセグメントは、2020年に59.5%のシェアで世界の除細動器市場を支配しています。 2020年の世界の成人患者数は約7,500万人(15歳以上)、小児患者数は約2,500万人(0〜14歳)となっています(出典:World Bank)。世界保健機関(WHO)のデータによると、全世界の死亡原因の約30%が心血管疾患によるもので、毎年1,790万人の命が失われています。CVD(心血管疾患)による死亡の約10人に2人は、65歳以下の患者で発生しています(出典:米国疾病対策センター)。心臓病の主な原因は、高血圧、高コレステロール、糖尿病、肥満、不健康な食生活、運動不足、アルコールの過剰摂取などです。 先進的なICD、CRT-D、AEDの開発に加えて、心疾患に対する意識の高まりや政府機関による予防措置が、市場の成長に寄与する大きな要因となっています。 "地域別では、APAC市場が予測期間中に最も高い成長率を記録する" 世界の除細動器市場は、大きく5つの地域に分けられます。北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカです。2020年の除細動器の世界市場では、北米が44.2%と最大のシェアを占め、欧州がそれに続きます。一方、アジア太平洋地域の市場は、予測期間中に最も高い成長率を記録すると予測されています。アジア太平洋地域の除細動器市場の成長を支えているのは、対象疾患の高負荷化、高齢者人口の増加、除細動器に関する認知度の向上などの要因が挙げられます。特に日本では、可処分所得の増加により先進技術を導入しやすい環境が整っていること、対象疾患の罹患率が高いこと、政府の取り組みが充実していることなどが要因となっています。このような要因は、この地域の市場を牽引し、海外からの投資や提携を呼び込むのに役立ちます。一方、一部の国では、病院の予算が少ないこと、機器のコストが高いこと、政府の投資が不足していることなどが、アジア太平洋地域の市場の成長を一定程度制限しています。 本レポートのために参照した主な参加企業の内訳は以下の通りです。 - 企業タイプ別。企業タイプ別: Tier1-25%、Tier2-37%、Tier3-38 - 呼称別Cレベル:34%、ディレクターレベル:35%、その他:31 - 地域別地域別:北米-24%、欧州-32%、アジア太平洋-28%、ラテンアメリカ-10%、中東・アフリカ-6 除細動器市場の著名プレイヤーには、Medtronic(アイルランド)、Stryker Corporation(米国)、Koninklijke Philips N.V.(オランダ)、旭化成株式会社(日本)、Boston Scientific Corporation(米国)、Abbott(米国)、日本光電工業株式会社(日本)、MicroPort(中国)などがあります。 リサーチカバレッジ 本レポートでは、除細動器市場を製品タイプ、患者タイプ、エンドユーザー、地域別に調査しています。また、市場成長に影響を与える要因を網羅し、市場におけるさまざまな機会や課題を分析し、市場リーダーの競争状況の詳細を明らかにします。さらに、個別の成長トレンドに関してマイクロマーケットを分析し、主要5地域(およびその地域の各国)に関して市場セグメントの収益を予測しています。 本レポートを購入する理由 本レポートは、既存の企業だけでなく、新規参入の企業や小規模な企業にとっても、市場の動向を把握するのに役立ち、ひいてはより大きな市場シェアを獲得するのに役立ちます。このレポートを購入した企業は、市場での存在感を高めるために、以下のような戦略の1つまたは複数の組み合わせを利用することができます。 本レポートでは、以下の点について分析しています。 市場への浸透。除細動器市場のトッププレイヤーが提供する製品ポートフォリオに関する包括的な情報 製品開発/イノベーション。除細動器市場の今後の動向、研究開発活動、製品の発売に関する詳細な情報を提供します。 市場の開拓有利な新興地域に関する包括的な情報 市場の多様化除細動器市場における新製品、成長地域、最近の開発状況に関する詳細な情報 競合他社の評価市場をリードする企業の市場セグメント、成長戦略、収益分析、製品などを詳細に評価します。 目次1 INTRODUCTION 281.1 OBJECTIVES OF THE STUDY 28 1.2 MARKET DEFINITION 28 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 29 1.3 MARKET SCOPE 29 1.3.1 MARKETS COVERED 29 1.3.2 YEARS CONSIDERED FOR THE STUDY 30 1.4 CURRENCY USED FOR THE STUDY 30 1.5 KEY MARKET STAKEHOLDERS 31 1.6 SUMMARY OF CHANGES 31 2 RESEARCH METHODOLOGY 32 2.1 RESEARCH DATA 32 FIGURE 1 RESEARCH DESIGN 32 2.1.1 SECONDARY DATA SOURCES 33 2.1.1.1 Indicative List of Secondary sources 34 2.1.2 PRIMARY DATA 34 FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION AND REGION 35 2.1.2.1 Key industry insights 36 2.2 MARKET SIZE ESTIMATION METHODOLOGY 36 FIGURE 3 REVENUE MAPPING-BASED MARKET ESTIMATION 37 FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 37 2.3 MARKET DATA VALIDATION AND TRIANGULATION 39 FIGURE 5 DATA TRIANGULATION METHODOLOGY 39 2.4 KEY RESEARCH ASSUMPTIONS 40 2.5 LIMITATIONS 40 2.5.1 METHODOLOGY-RELATED LIMITATIONS 40 2.6 RISK ASSESSMENT 41 TABLE 1 RISK ASSESSMENT: DEFIBRILLATORS MARKET 41 2.7 COVID-19 HEALTH ASSESSMENT 41 2.8 COVID-19 ECONOMIC ASSESSMENT 41 2.9 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 42 FIGURE 6 CRITERIA IMPACTING THE GLOBAL ECONOMY 42 FIGURE 7 RECOVERY SCENARIO OF THE GLOBAL ECONOMY (2021–2022) 43 3 EXECUTIVE SUMMARY 44 FIGURE 8 DEFIBRILLATORS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 44 FIGURE 9 DEFIBRILLATORS MARKET SHARE, BY END USER, 2020 VS. 2026 45 FIGURE 10 DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021 VS. 2026 46 FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE DEFIBRILLATORS MARKET 46 4 PREMIUM INSIGHTS 48 4.1 DEFIBRILLATORS MARKET OVERVIEW 48 FIGURE 12 RISING PREVALENCE OF TARGET DISEASES TO DRIVE MARKET GROWTH 48 4.2 DEFIBRILLATORS MARKET, BY REGION AND END USER, 2020 (USD MILLION) 49 FIGURE 13 HOSPITALS, CLINICS, AND CARDIAC CENTERS TO DOMINATE THE DEFIBRILLATORS MARKET, BY END USER, IN 2020 49 4.3 DEFIBRILLATORS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 50 FIGURE 14 IMPLANTABLE DEFIBRILLATORS WILL CONTINUE TO DOMINATE THE DEFIBRILLATORS MARKET IN 2026 50 4.4 GEOGRAPHIC SNAPSHOT OF THE DEFIBRILLATORS MARKET 50 FIGURE 15 ASIA PACIFIC IS THE FASTEST-GROWING MARKET FOR DEFIBRILLATORS 50 5 MARKET OVERVIEW 51 5.1 INTRODUCTION 51 5.2 MARKET DYNAMICS 51 FIGURE 16 DEFIBRILLATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 51 5.2.1 DRIVERS 52 5.2.1.1 Rising prevalence of target diseases 52 FIGURE 17 GERIATRIC POPULATION, BY REGION, 2019 VS. 2030 (THOUSAND) 52 5.2.1.2 Growing focus on providing public-access defibrillators 53 5.2.1.3 Training & awareness programs on defibrillators 53 5.2.2 RESTRAINTS 54 5.2.2.1 Issues related to the use of implantable and automated external defibrillators 54 5.2.3 OPPORTUNITIES 55 5.2.3.1 Emerging markets 55 5.2.3.2 Development of S-ICDs and MRI-compatible ICDs & CRT-Ds 55 5.2.4 CHALLENGES 56 5.2.4.1 Frequent product recalls 56 TABLE 2 RECENT PRODUCT RECALLS BY THE US FDA, 2018–2021 56 5.2.4.2 Lack of awareness about sudden cardiac arrest in developing nations 56 5.3 INDUSTRY TRENDS 57 5.3.1 INCREASING PRICING PRESSURE ON MARKET PLAYERS 57 5.3.2 GROWING NUMBER OF MERGERS & ACQUISITIONS AMONG MARKET PLAYERS 57 5.3.3 RISING DEMAND FOR AUTOMATED EXTERNAL DEFIBRILLATORS IN PREHOSPITAL SETTINGS 58 5.4 PRICING ANALYSIS 58 TABLE 3 PRICING ANALYSIS: DEFIBRILLATORS MARKET, 2021 (USD) 58 5.5 REGULATORY ANALYSIS 58 TABLE 4 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING THE DEFIBRILLATORS MARKET 58 5.5.1 NORTH AMERICA 59 5.5.1.1 US 59 TABLE 5 CLASSIFICATION OF MEDICAL DEVICES BY THE US FDA 59 TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 60 5.5.1.2 Canada 60 TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 60 5.5.2 EUROPE 61 5.5.3 ASIA PACIFIC 61 5.5.3.1 Japan 61 TABLE 8 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 61 5.5.3.2 China 62 TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES 62 5.5.3.3 India 63 5.6 VALUE CHAIN ANALYSIS 64 5.6.1 RESEARCH & DEVELOPMENT 64 5.6.2 MANUFACTURING & ASSEMBLY 64 5.6.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES 64 FIGURE 18 DEFIBRILLATORS MARKET: VALUE CHAIN ANALYSIS 64 5.7 ECOSYSTEM LANDSCAPE 65 5.8 REIMBURSEMENT SCENARIO 65 TABLE 10 MEDICAL REIMBURSEMENT CODES FOR DEFIBRILLATOR PROCEDURES IN THE US 2021 66 5.9 PORTER’S FIVE FORCES ANALYSIS 67 TABLE 11 DEFIBRILLATORS MARKET: PORTER’S FIVE FORCES ANALYSIS 67 5.9.1 THREAT FROM NEW ENTRANTS 67 5.9.2 THREAT FROM SUBSTITUTES 67 5.9.3 BARGAINING POWER OF SUPPLIERS 67 5.9.4 BARGAINING POWER OF BUYERS 68 5.9.5 INTENSITY OF COMPETITIVE RIVALRY 68 5.10 IMPACT OF COVID-19 ON THE DEFIBRILLATORS MARKET 68 5.11 PATENT ANALYSIS 69 5.11.1 PATENTS GRANTED FOR DEFIBRILLATORS 69 FIGURE 19 PATENTS GRANTED FOR DEFIBRILLATORS (JANUARY 2011 TO SEPTEMBER 2021) 69 5.11.2 JURISDICTION AND TOP APPLICANT ANALYSIS 69 TABLE 12 TOP 20 PATENT OWNERS FOR DEFIBRILLATORS (JANUARY 2011 TO SEPTEMBER 2021) 69 FIGURE 20 TOP 10 PATENT APPLICANTS FOR DEFIBRILLATORS (JANUARY 2011 TO SEPTEMBER 2021) 70 FIGURE 21 PATENT DOCUMENTS FOR DEFIBRILLATORS, BY JURISDICTION (JANUARY 2011 TO SEPTEMBER 2021) 71 6 DEFIBRILLATORS MARKET, BY TYPE 72 6.1 INTRODUCTION 73 TABLE 13 DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 73 TABLE 14 DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 73 TABLE 15 DEFIBRILLATORS MARKET, BY END USER, 2018–2026 (USD MILLION) 74 TABLE 16 DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 74 6.2 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 74 TABLE 17 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 75 TABLE 18 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 75 TABLE 19 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 76 TABLE 20 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY END USER, 2018–2026 (USD MILLION) 76 6.2.1 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 77 TABLE 21 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 77 TABLE 22 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 77 6.2.1.1 Biventricular ICDs/cardiac resynchronization therapy defibrillators 78 6.2.1.1.1 Launch of technologically advanced CRT-D devices to support market growth 78 TABLE 23 BIVENTRICULAR ICDS/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 79 6.2.1.2 Dual-chamber ICDs 79 6.2.1.2.1 Dual-chamber ICDs reduce the incidence of inappropriate shocks—a key factor driving market growth 79 TABLE 24 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 80 6.2.1.3 Single-chamber ICDs 80 6.2.1.3.1 Single-chamber ICDs are associated with the increased risk of inappropriate shocks—a key factor limiting market growth 80 TABLE 25 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 81 6.2.2 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 81 6.2.2.1 S-ICDs segment to register the highest growth in the ICDs market 81 TABLE 26 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 82 6.3 EXTERNAL DEFIBRILLATORS 82 TABLE 27 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 82 TABLE 28 EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 83 TABLE 29 EXTERNAL DEFIBRILLATORS MARKET, BY END USER, 2018–2026 (USD MILLION) 83 TABLE 30 EXTERNAL DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 83 6.3.1 MANUAL & SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS 84 6.3.1.1 Development of technologically advanced AEDs negatively affects the market for manual external defibrillators 84 TABLE 31 MANUAL & SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 85 6.3.2 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS 85 6.3.2.1 Increasing installation of these devices in public places to drive market growth 85 TABLE 32 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 86 6.3.3 WEARABLE CARDIOVERTER DEFIBRILLATORS 86 6.3.3.1 Concerns associated with the use of WCDs are expected to hamper their adoption 86 TABLE 33 WEARABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 87 7 DEFIBRILLATORS MARKET, BY PATIENT TYPE 88 7.1 INTRODUCTION 89 TABLE 34 DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 89 7.2 ADULT PATIENTS 89 7.2.1 ADVANCEMENTS IN DEFIBRILLATION TECHNIQUES TO BOOST ADOPTION OF DEFIBRILLATORS AMONG ADULT PATIENTS 89 TABLE 35 DEFIBRILLATORS MARKET FOR ADULT PATIENTS, BY REGION, 2018–2026 (USD MILLION) 90 7.3 PEDIATRIC PATIENTS 90 7.3.1 INCREASING INCIDENCE OF PEDIATRIC HEART AILMENTS TO DRIVE MARKET GROWTH 90 TABLE 36 DEFIBRILLATORS MARKET FOR PEDIATRIC PATIENTS, BY REGION, 2018–2026 (USD MILLION) 91 8 DEFIBRILLATORS MARKET, BY END USER 92 8.1 INTRODUCTION 93 TABLE 37 DEFIBRILLATORS MARKET, BY END USER TYPE, 2018–2026 (USD MILLION) 93 8.2 HOSPITALS, CLINICS, AND CARDIAC CENTERS 93 8.2.1 MOST ICD PROCEDURES ARE CARRIED OUT IN HOSPITALS, CLINICS, AND CARDIAC CENTERS—A KEY FACTOR DRIVING MARKET GROWTH 93 TABLE 38 DEFIBRILLATORS MARKET FOR HOSPITALS, CLINICS, AND CARDIAC CENTERS, BY REGION, 2018–2026 (USD MILLION) 94 8.3 PREHOSPITAL CARE SETTINGS 94 8.3.1 GROWING FUNDING FOR PREHOSPITAL EMERGENCY AMBULANCE SERVICES IN DEVELOPING COUNTRIES TO SUPPORT MARKET GROWTH 94 TABLE 39 DEFIBRILLATORS MARKET FOR PREHOSPITAL CARE SETTINGS, BY REGION, 2018–2026 (USD MILLION) 95 8.4 PUBLIC-ACCESS MARKETS 95 8.4.1 RISING INCIDENCE OF OUT-OF-HOSPITAL CARDIAC ARRESTS TO DRIVE THE ADOPTION OF DEFIBRILLATORS 95 TABLE 40 DEFIBRILLATORS MARKET FOR PUBLIC-ACCESS MARKETS, BY REGION, 2018–2026 (USD MILLION) 96 8.5 ALTERNATE CARE FACILITIES 96 8.5.1 UNDERDEVELOPED INFRASTRUCTURE FOR ALTERNATE CARE IN MOST EUROPEAN COUNTRIES AND EMERGING NATIONS TO RESTRAIN MARKET GROWTH 96 TABLE 41 DEFIBRILLATORS MARKET FOR ALTERNATE CARE FACILITIES, BY REGION, 2018–2026 (USD MILLION) 96 8.6 HOME CARE SETTINGS 97 8.6.1 INCREASING ADOPTION OF HOME AUTOMATED EXTERNAL DEFIBRILLATORS—A KEY FACTOR DRIVING MARKET GROWTH 97 TABLE 42 DEFIBRILLATORS MARKET FOR HOME CARE SETTINGS, BY REGION, 2018–2026 (USD MILLION) 97 8.7 OTHER END USERS 98 TABLE 43 DEFIBRILLATORS MARKET FOR OTHER END USERS, BY REGION, 2018–2026 (USD MILLION) 98 9 DEFIBRILLATORS MARKET, BY REGION 99 9.1 INTRODUCTION 100 FIGURE 22 GEOGRAPHIC SNAPSHOT OF THE DEFIBRILLATORS MARKET 100 TABLE 44 DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 100 9.2 NORTH AMERICA 101 FIGURE 23 NORTH AMERICA: DEFIBRILLATORS MARKET SNAPSHOT 101 TABLE 45 NORTH AMERICA: DEFIBRILLATORS MARKET, BY COUNTRY, 2018–2026 (USD MILLION) 102 TABLE 46 NORTH AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 102 TABLE 47 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 102 TABLE 48 NORTH AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 103 TABLE 49 NORTH AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 103 TABLE 50 NORTH AMERICA: DEFIBRILLATORS MARKET, BY END USER, 2018–2026 (USD MILLION) 104 TABLE 51 NORTH AMERICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 104 9.2.1 US 104 9.2.1.1 High adoption rate of AEDs in the country to drive market growth 104 TABLE 52 US: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 106 TABLE 53 US: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 106 TABLE 54 US: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 106 TABLE 55 US: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 107 9.2.2 CANADA 107 9.2.2.1 High burden of CVDs in the country contributes to the growth of the defibrillators market in Canada 107 TABLE 56 CANADA: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 108 TABLE 57 CANADA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 108 TABLE 58 CANADA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 108 TABLE 59 CANADA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 109 9.3 EUROPE 109 TABLE 60 EUROPE: DEFIBRILLATORS MARKET, BY COUNTRY, 2018–2026 (USD MILLION) 109 TABLE 61 EUROPE: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 110 TABLE 62 EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 110 TABLE 63 EUROPE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 110 TABLE 64 EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 111 TABLE 65 EUROPE: DEFIBRILLATORS MARKET, BY END USER, 2018–2026 (USD MILLION) 111 TABLE 66 EUROPE: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 112 9.3.1 GERMANY 112 9.3.1.1 Presence of non-profit organizations that provide defibrillator services in the country to drive market growth in Germany 112 TABLE 67 GERMANY: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 113 TABLE 68 GERMANY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 113 TABLE 69 GERMANY: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 113 TABLE 70 GERMANY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 114 9.3.2 UK 114 9.3.2.1 Rising support from government and private organizations and increasing awareness related to defibrillators are fueling market growth 114 TABLE 71 UK: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 115 TABLE 72 UK: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 115 TABLE 73 UK: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 115 TABLE 74 UK: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 116 9.3.3 FRANCE 116 9.3.3.1 Increasing prevalence of chronic diseases in the geriatric population—a key driver for market growth in France 116 TABLE 75 FRANCE: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 117 TABLE 76 FRANCE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 117 TABLE 77 FRANCE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 117 TABLE 78 FRANCE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 118 9.3.4 ITALY 118 9.3.4.1 High prevalence of OHCA in the country is driving the growth of the defibrillators market in Italy 118 TABLE 79 ITALY: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 118 TABLE 80 ITALY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 119 TABLE 81 ITALY: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 119 TABLE 82 ITALY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 119 9.3.5 SPAIN 120 9.3.5.1 Increasing number of conferences and awareness programs to support the growth of the defibrillators market in Spain 120 TABLE 83 SPAIN: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 120 TABLE 84 SPAIN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 120 TABLE 85 SPAIN: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 121 TABLE 86 SPAIN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 121 9.3.6 REST OF EUROPE 121 TABLE 87 ROE: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 122 TABLE 88 ROE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 122 TABLE 89 ROE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 122 TABLE 90 ROE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 123 9.4 ASIA PACIFIC 123 FIGURE 24 ASIA PACIFIC: DEFIBRILLATORS MARKET SNAPSHOT 124 TABLE 91 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY COUNTRY, 2018–2026 (USD MILLION) 125 TABLE 92 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 125 TABLE 93 ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 125 TABLE 94 ASIA PACIFIC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 126 TABLE 95 ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 126 TABLE 96 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY END USER, 2018–2026 (USD MILLION) 127 TABLE 97 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 127 9.4.1 JAPAN 127 9.4.1.1 Presence of a universal insurance scheme in Japan to support market growth 127 TABLE 98 JAPAN: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 128 TABLE 99 JAPAN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 128 TABLE 100 JAPAN: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 129 TABLE 101 JAPAN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 129 9.4.2 CHINA 129 9.4.2.1 Growing focus of market players on expanding their presence in China to drive market growth 129 TABLE 102 CHINA: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 130 TABLE 103 CHINA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 130 TABLE 104 CHINA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 131 TABLE 105 CHINA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 131 9.4.3 INDIA 131 9.4.3.1 High incidence and prevalence of CVDs in the country to drive market growth 131 TABLE 106 INDIA: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 132 TABLE 107 INDIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 132 TABLE 108 INDIA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 133 TABLE 109 INDIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 133 9.4.4 AUSTRALIA 133 9.4.4.1 Measures taken by government and private bodies to make AEDs available at public sites in the country to drive market growth 133 TABLE 110 AUSTRALIA: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 134 TABLE 111 AUSTRALIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 134 TABLE 112 AUSTRALIA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 134 TABLE 113 AUSTRALIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 135 9.4.5 SOUTH KOREA 135 9.4.5.1 Rising incidence of cardiac disorders to drive the growth of the defibrillators market in South Korea 135 TABLE 114 SOUTH KOREA: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 135 TABLE 115 SOUTH KOREA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 136 TABLE 116 SOUTH KOREA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 136 TABLE 117 SOUTH KOREA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 136 9.4.6 REST OF ASIA PACIFIC (ROAPAC) 137 TABLE 118 REST OF ASIA PACIFIC: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 137 TABLE 119 REST OF ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 138 TABLE 120 REST OF ASIA PACIFIC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 138 TABLE 121 REST OF ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 138 9.5 LATIN AMERICA 139 TABLE 122 LATIN AMERICA: DEFIBRILLATORS MARKET, BY COUNTRY, 2018–2026 (USD MILLION) 139 TABLE 123 LATIN AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 139 TABLE 124 LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 140 TABLE 125 LATIN AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 140 TABLE 126 LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 140 TABLE 127 LATIN AMERICA: DEFIBRILLATORS MARKET, BY END USER, 2018–2026 (USD MILLION) 141 TABLE 128 LATIN AMERICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 141 9.5.1 BRAZIL 141 9.5.1.1 Large obese population in the country results in an increased demand for defibrillators 141 TABLE 129 BRAZIL: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 142 TABLE 130 BRAZIL: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 142 TABLE 131 BRAZIL: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 142 TABLE 132 BRAZIL: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 143 9.5.2 MEXICO 143 9.5.2.1 High prevalence of target diseases in the country to drive the growth of the defibrillators market in Mexico 143 TABLE 133 MEXICO: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 143 TABLE 134 MEXICO: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 144 TABLE 135 MEXICO: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 144 TABLE 136 MEXICO: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 144 9.5.3 REST OF LATIN AMERICA 145 TABLE 137 REST OF LATIN AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 145 TABLE 138 REST OF LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 145 TABLE 139 REST OF LATIN AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 146 TABLE 140 REST OF LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 146 9.6 MIDDLE EAST & AFRICA 147 TABLE 141 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 147 TABLE 142 MIDDLE EAST & AFRICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 147 TABLE 143 MIDDLE EAST & AFRICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 148 TABLE 144 MIDDLE EAST & AFRICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 148 TABLE 145 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY END USER, 2018–2026 (USD MILLION) 149 TABLE 146 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 149 10 COMPETITIVE LANDSCAPE 150 10.1 INTRODUCTION 150 FIGURE 25 KEY DEVELOPMENTS BY LEADING PLAYERS IN THE DEFIBRILLATORS MARKET, 2018–2021 150 10.2 REVENUE SHARE ANALYSIS 151 FIGURE 26 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE DEFIBRILLATORS MARKET 151 10.3 MARKET SHARE ANALYSIS 152 FIGURE 27 DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER, 2020 152 TABLE 147 DEFIBRILLATOR MARKET: DEGREE OF COMPETITION 152 10.4 COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2020) 154 10.4.1 TERMINOLOGY/NOMENCLATURE 154 10.4.1.1 Stars 154 10.4.1.2 Emerging leaders 154 10.4.1.3 Pervasive players 154 10.4.1.4 Participants 154 FIGURE 28 DEFIBRILLATORS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020 155 10.5 COMPETITIVE LEADERSHIP MAPPING: START-UP/SME EVALUATION QUADRANT (AS OF 2020) 156 10.5.1 PROGRESSIVE COMPANIES 156 10.5.2 RESPONSIVE COMPANIES 156 10.5.3 DYNAMIC COMPANIES 156 10.5.4 STARTING BLOCKS 156 FIGURE 29 DEFIBRILLATORS MARKET: COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS) 157 10.6 COMPETITIVE BENCHMARKING 158 TABLE 148 PRODUCT FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE DEFIBRILLATORS MARKET 158 TABLE 149 END-USER FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE DEFIBRILLATOR MARKET 159 TABLE 150 COMPANY FOOTPRINT ANALYSIS IN THE DEFIBRILLATORS MARKET 160 10.7 COMPETITIVE SCENARIO (2018–2021) 161 10.7.1 NEW PRODUCT LAUNCHES & APPROVALS 161 10.7.2 DEALS 162 10.7.3 OTHER DEVELOPMENTS 162 11 COMPANY PROFILES 164 11.1 KEY PLAYERS 164 (Business overview, Products offered, Recent developments, MNM view)* 11.1.1 MEDTRONIC 164 TABLE 151 MEDTRONIC: BUSINESS OVERVIEW 164 FIGURE 30 MEDTRONIC PLC: COMPANY SNAPSHOT (2020) 165 11.1.2 STRYKER CORPORATION 169 TABLE 152 STRYKER CORPORATION: BUSINESS OVERVIEW 169 FIGURE 31 STRYKER CORPORATION: COMPANY SNAPSHOT (2020) 170 11.1.3 KONINKLIJKE PHILIPS N.V. 172 TABLE 153 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 172 FIGURE 32 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020) 173 11.1.4 ASAHI KASEI CORPORATION 176 TABLE 154 ASAHI KASEI CORPORATION: BUSINESS OVERVIEW 176 FIGURE 33 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2020) 177 11.1.5 BOSTON SCIENTIFIC CORPORATION 179 TABLE 155 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 179 FIGURE 34 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020) 180 11.1.6 ABBOTT 183 TABLE 156 ABBOTT: BUSINESS OVERVIEW 183 FIGURE 35 ABBOTT: COMPANY SNAPSHOT (2020) 184 11.1.7 MICROPORT 186 TABLE 157 MICROPORT: BUSINESS OVERVIEW 186 FIGURE 36 MICROPORT: COMPANY SNAPSHOT (2020) 187 11.1.8 NIHON KOHDEN CORPORATION 189 TABLE 158 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW 189 FIGURE 37 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2020) 190 11.1.9 BIOTRONIK 192 TABLE 159 BIOTRONIK: BUSINESS OVERVIEW 192 11.1.10 CU MEDICAL SYSTEMS INC. 194 TABLE 160 CU MEDICAL SYSTEMS INC.: BUSINESS OVERVIEW 194 FIGURE 38 CU MEDICAL SYSTEMS INC.: COMPANY SNAPSHOT (2020) 194 11.1.11 METSIS MEDIKAL 196 TABLE 161 METSIS MEDIKAL: BUSINESS OVERVIEW 196 11.1.12 MEDIANA CO. LTD. 197 TABLE 162 MEDIANA CO. LTD.: BUSINESS OVERVIEW 197 FIGURE 39 MEDIANA CO. LTD.: COMPANY SNAPSHOT (2020) 197 11.1.13 MINDRAY MEDICAL INTERNATIONAL LIMITED 199 TABLE 163 MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW 199 FIGURE 40 MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2020) 200 11.1.14 PROGETTI SRL - MEDICAL EQUIPMENT SOLUTIONS 202 TABLE 164 PROGETTI SRL – MEDICAL EQUIPMENT SOLUTIONS: BUSINESS OVERVIEW 202 11.1.15 SCHILLER AG 203 TABLE 165 SCHILLER AG: BUSINESS OVERVIEW 203 11.2 OTHER PLAYERS 205 11.2.1 BPL MEDICAL TECHNOLOGIES 205 TABLE 166 BPL MEDICAL TECHNOLOGIES: BUSINESS OVERVIEW 205 11.2.2 METRAX GMBH (PRIMEDIC) 206 TABLE 167 METRAX GMBH (PRIMEDIC): BUSINESS OVERVIEW 206 11.2.3 MS WESTFALIA GMBH 207 TABLE 168 MS WESTFALIA GMBH: BUSINESS OVERVIEW 207 11.2.4 BEXEN CARDIO 208 TABLE 169 BEXEN CARDIO: BUSINESS OVERVIEW 208 11.2.5 AXION MEDICAL EQUIPMENT LTD. 210 TABLE 170 AXION MEDICAL EQUIPMENT LTD.: BUSINESS OVERVIEW 210 11.2.6 ELEMENT SCIENCE INC. 211 TABLE 171 ELEMENT SCIENCE INC.: BUSINESS OVERVIEW 211 11.2.7 AVIVE SOLUTIONS INC. 212 TABLE 172 AVIVE SOLUTIONS INC.: BUSINESS OVERVIEW 212 11.2.8 JEEVTRONICS PVT. LTD. 213 TABLE 173 JEEVTRONICS PVT. LTD.: BUSINESS OVERVIEW 213 11.2.9 HEARTHERO INC. 214 TABLE 174 HEARTHERO INC.: BUSINESS OVERVIEW 214 11.2.10 SHENZHEN COMEN MEDICAL INSTRUMENTS LTD. 215 TABLE 175 SHENZHEN COMEN MEDICAL INSTRUMENTS LTD.: BUSINESS OVERVIEW 215 *Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies. 12 APPENDIX 216 12.1 DISCUSSION GUIDE 216 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 220 12.3 AVAILABLE CUSTOMIZATIONS 222 12.4 RELATED REPORTS 223 12.5 AUTHOR DETAILS 224
SummaryThe global defibrillator market is expected to reach USD 18.2 billion by 2026 from an estimated USD 11.4 billion in 2021, at a CAGR of 9.7% from 2021 to 2026. Table of Contents1 INTRODUCTION 281.1 OBJECTIVES OF THE STUDY 28 1.2 MARKET DEFINITION 28 1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 29 1.3 MARKET SCOPE 29 1.3.1 MARKETS COVERED 29 1.3.2 YEARS CONSIDERED FOR THE STUDY 30 1.4 CURRENCY USED FOR THE STUDY 30 1.5 KEY MARKET STAKEHOLDERS 31 1.6 SUMMARY OF CHANGES 31 2 RESEARCH METHODOLOGY 32 2.1 RESEARCH DATA 32 FIGURE 1 RESEARCH DESIGN 32 2.1.1 SECONDARY DATA SOURCES 33 2.1.1.1 Indicative List of Secondary sources 34 2.1.2 PRIMARY DATA 34 FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION AND REGION 35 2.1.2.1 Key industry insights 36 2.2 MARKET SIZE ESTIMATION METHODOLOGY 36 FIGURE 3 REVENUE MAPPING-BASED MARKET ESTIMATION 37 FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 37 2.3 MARKET DATA VALIDATION AND TRIANGULATION 39 FIGURE 5 DATA TRIANGULATION METHODOLOGY 39 2.4 KEY RESEARCH ASSUMPTIONS 40 2.5 LIMITATIONS 40 2.5.1 METHODOLOGY-RELATED LIMITATIONS 40 2.6 RISK ASSESSMENT 41 TABLE 1 RISK ASSESSMENT: DEFIBRILLATORS MARKET 41 2.7 COVID-19 HEALTH ASSESSMENT 41 2.8 COVID-19 ECONOMIC ASSESSMENT 41 2.9 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 42 FIGURE 6 CRITERIA IMPACTING THE GLOBAL ECONOMY 42 FIGURE 7 RECOVERY SCENARIO OF THE GLOBAL ECONOMY (2021–2022) 43 3 EXECUTIVE SUMMARY 44 FIGURE 8 DEFIBRILLATORS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 44 FIGURE 9 DEFIBRILLATORS MARKET SHARE, BY END USER, 2020 VS. 2026 45 FIGURE 10 DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021 VS. 2026 46 FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE DEFIBRILLATORS MARKET 46 4 PREMIUM INSIGHTS 48 4.1 DEFIBRILLATORS MARKET OVERVIEW 48 FIGURE 12 RISING PREVALENCE OF TARGET DISEASES TO DRIVE MARKET GROWTH 48 4.2 DEFIBRILLATORS MARKET, BY REGION AND END USER, 2020 (USD MILLION) 49 FIGURE 13 HOSPITALS, CLINICS, AND CARDIAC CENTERS TO DOMINATE THE DEFIBRILLATORS MARKET, BY END USER, IN 2020 49 4.3 DEFIBRILLATORS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 50 FIGURE 14 IMPLANTABLE DEFIBRILLATORS WILL CONTINUE TO DOMINATE THE DEFIBRILLATORS MARKET IN 2026 50 4.4 GEOGRAPHIC SNAPSHOT OF THE DEFIBRILLATORS MARKET 50 FIGURE 15 ASIA PACIFIC IS THE FASTEST-GROWING MARKET FOR DEFIBRILLATORS 50 5 MARKET OVERVIEW 51 5.1 INTRODUCTION 51 5.2 MARKET DYNAMICS 51 FIGURE 16 DEFIBRILLATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 51 5.2.1 DRIVERS 52 5.2.1.1 Rising prevalence of target diseases 52 FIGURE 17 GERIATRIC POPULATION, BY REGION, 2019 VS. 2030 (THOUSAND) 52 5.2.1.2 Growing focus on providing public-access defibrillators 53 5.2.1.3 Training & awareness programs on defibrillators 53 5.2.2 RESTRAINTS 54 5.2.2.1 Issues related to the use of implantable and automated external defibrillators 54 5.2.3 OPPORTUNITIES 55 5.2.3.1 Emerging markets 55 5.2.3.2 Development of S-ICDs and MRI-compatible ICDs & CRT-Ds 55 5.2.4 CHALLENGES 56 5.2.4.1 Frequent product recalls 56 TABLE 2 RECENT PRODUCT RECALLS BY THE US FDA, 2018–2021 56 5.2.4.2 Lack of awareness about sudden cardiac arrest in developing nations 56 5.3 INDUSTRY TRENDS 57 5.3.1 INCREASING PRICING PRESSURE ON MARKET PLAYERS 57 5.3.2 GROWING NUMBER OF MERGERS & ACQUISITIONS AMONG MARKET PLAYERS 57 5.3.3 RISING DEMAND FOR AUTOMATED EXTERNAL DEFIBRILLATORS IN PREHOSPITAL SETTINGS 58 5.4 PRICING ANALYSIS 58 TABLE 3 PRICING ANALYSIS: DEFIBRILLATORS MARKET, 2021 (USD) 58 5.5 REGULATORY ANALYSIS 58 TABLE 4 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING THE DEFIBRILLATORS MARKET 58 5.5.1 NORTH AMERICA 59 5.5.1.1 US 59 TABLE 5 CLASSIFICATION OF MEDICAL DEVICES BY THE US FDA 59 TABLE 6 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 60 5.5.1.2 Canada 60 TABLE 7 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 60 5.5.2 EUROPE 61 5.5.3 ASIA PACIFIC 61 5.5.3.1 Japan 61 TABLE 8 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 61 5.5.3.2 China 62 TABLE 9 CHINA: CLASSIFICATION OF MEDICAL DEVICES 62 5.5.3.3 India 63 5.6 VALUE CHAIN ANALYSIS 64 5.6.1 RESEARCH & DEVELOPMENT 64 5.6.2 MANUFACTURING & ASSEMBLY 64 5.6.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES 64 FIGURE 18 DEFIBRILLATORS MARKET: VALUE CHAIN ANALYSIS 64 5.7 ECOSYSTEM LANDSCAPE 65 5.8 REIMBURSEMENT SCENARIO 65 TABLE 10 MEDICAL REIMBURSEMENT CODES FOR DEFIBRILLATOR PROCEDURES IN THE US 2021 66 5.9 PORTER’S FIVE FORCES ANALYSIS 67 TABLE 11 DEFIBRILLATORS MARKET: PORTER’S FIVE FORCES ANALYSIS 67 5.9.1 THREAT FROM NEW ENTRANTS 67 5.9.2 THREAT FROM SUBSTITUTES 67 5.9.3 BARGAINING POWER OF SUPPLIERS 67 5.9.4 BARGAINING POWER OF BUYERS 68 5.9.5 INTENSITY OF COMPETITIVE RIVALRY 68 5.10 IMPACT OF COVID-19 ON THE DEFIBRILLATORS MARKET 68 5.11 PATENT ANALYSIS 69 5.11.1 PATENTS GRANTED FOR DEFIBRILLATORS 69 FIGURE 19 PATENTS GRANTED FOR DEFIBRILLATORS (JANUARY 2011 TO SEPTEMBER 2021) 69 5.11.2 JURISDICTION AND TOP APPLICANT ANALYSIS 69 TABLE 12 TOP 20 PATENT OWNERS FOR DEFIBRILLATORS (JANUARY 2011 TO SEPTEMBER 2021) 69 FIGURE 20 TOP 10 PATENT APPLICANTS FOR DEFIBRILLATORS (JANUARY 2011 TO SEPTEMBER 2021) 70 FIGURE 21 PATENT DOCUMENTS FOR DEFIBRILLATORS, BY JURISDICTION (JANUARY 2011 TO SEPTEMBER 2021) 71 6 DEFIBRILLATORS MARKET, BY TYPE 72 6.1 INTRODUCTION 73 TABLE 13 DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 73 TABLE 14 DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 73 TABLE 15 DEFIBRILLATORS MARKET, BY END USER, 2018–2026 (USD MILLION) 74 TABLE 16 DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 74 6.2 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 74 TABLE 17 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 75 TABLE 18 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 75 TABLE 19 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 76 TABLE 20 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY END USER, 2018–2026 (USD MILLION) 76 6.2.1 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 77 TABLE 21 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 77 TABLE 22 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 77 6.2.1.1 Biventricular ICDs/cardiac resynchronization therapy defibrillators 78 6.2.1.1.1 Launch of technologically advanced CRT-D devices to support market growth 78 TABLE 23 BIVENTRICULAR ICDS/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 79 6.2.1.2 Dual-chamber ICDs 79 6.2.1.2.1 Dual-chamber ICDs reduce the incidence of inappropriate shocks—a key factor driving market growth 79 TABLE 24 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 80 6.2.1.3 Single-chamber ICDs 80 6.2.1.3.1 Single-chamber ICDs are associated with the increased risk of inappropriate shocks—a key factor limiting market growth 80 TABLE 25 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 81 6.2.2 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS 81 6.2.2.1 S-ICDs segment to register the highest growth in the ICDs market 81 TABLE 26 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 82 6.3 EXTERNAL DEFIBRILLATORS 82 TABLE 27 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 82 TABLE 28 EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 83 TABLE 29 EXTERNAL DEFIBRILLATORS MARKET, BY END USER, 2018–2026 (USD MILLION) 83 TABLE 30 EXTERNAL DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 83 6.3.1 MANUAL & SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS 84 6.3.1.1 Development of technologically advanced AEDs negatively affects the market for manual external defibrillators 84 TABLE 31 MANUAL & SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 85 6.3.2 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS 85 6.3.2.1 Increasing installation of these devices in public places to drive market growth 85 TABLE 32 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 86 6.3.3 WEARABLE CARDIOVERTER DEFIBRILLATORS 86 6.3.3.1 Concerns associated with the use of WCDs are expected to hamper their adoption 86 TABLE 33 WEARABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 87 7 DEFIBRILLATORS MARKET, BY PATIENT TYPE 88 7.1 INTRODUCTION 89 TABLE 34 DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 89 7.2 ADULT PATIENTS 89 7.2.1 ADVANCEMENTS IN DEFIBRILLATION TECHNIQUES TO BOOST ADOPTION OF DEFIBRILLATORS AMONG ADULT PATIENTS 89 TABLE 35 DEFIBRILLATORS MARKET FOR ADULT PATIENTS, BY REGION, 2018–2026 (USD MILLION) 90 7.3 PEDIATRIC PATIENTS 90 7.3.1 INCREASING INCIDENCE OF PEDIATRIC HEART AILMENTS TO DRIVE MARKET GROWTH 90 TABLE 36 DEFIBRILLATORS MARKET FOR PEDIATRIC PATIENTS, BY REGION, 2018–2026 (USD MILLION) 91 8 DEFIBRILLATORS MARKET, BY END USER 92 8.1 INTRODUCTION 93 TABLE 37 DEFIBRILLATORS MARKET, BY END USER TYPE, 2018–2026 (USD MILLION) 93 8.2 HOSPITALS, CLINICS, AND CARDIAC CENTERS 93 8.2.1 MOST ICD PROCEDURES ARE CARRIED OUT IN HOSPITALS, CLINICS, AND CARDIAC CENTERS—A KEY FACTOR DRIVING MARKET GROWTH 93 TABLE 38 DEFIBRILLATORS MARKET FOR HOSPITALS, CLINICS, AND CARDIAC CENTERS, BY REGION, 2018–2026 (USD MILLION) 94 8.3 PREHOSPITAL CARE SETTINGS 94 8.3.1 GROWING FUNDING FOR PREHOSPITAL EMERGENCY AMBULANCE SERVICES IN DEVELOPING COUNTRIES TO SUPPORT MARKET GROWTH 94 TABLE 39 DEFIBRILLATORS MARKET FOR PREHOSPITAL CARE SETTINGS, BY REGION, 2018–2026 (USD MILLION) 95 8.4 PUBLIC-ACCESS MARKETS 95 8.4.1 RISING INCIDENCE OF OUT-OF-HOSPITAL CARDIAC ARRESTS TO DRIVE THE ADOPTION OF DEFIBRILLATORS 95 TABLE 40 DEFIBRILLATORS MARKET FOR PUBLIC-ACCESS MARKETS, BY REGION, 2018–2026 (USD MILLION) 96 8.5 ALTERNATE CARE FACILITIES 96 8.5.1 UNDERDEVELOPED INFRASTRUCTURE FOR ALTERNATE CARE IN MOST EUROPEAN COUNTRIES AND EMERGING NATIONS TO RESTRAIN MARKET GROWTH 96 TABLE 41 DEFIBRILLATORS MARKET FOR ALTERNATE CARE FACILITIES, BY REGION, 2018–2026 (USD MILLION) 96 8.6 HOME CARE SETTINGS 97 8.6.1 INCREASING ADOPTION OF HOME AUTOMATED EXTERNAL DEFIBRILLATORS—A KEY FACTOR DRIVING MARKET GROWTH 97 TABLE 42 DEFIBRILLATORS MARKET FOR HOME CARE SETTINGS, BY REGION, 2018–2026 (USD MILLION) 97 8.7 OTHER END USERS 98 TABLE 43 DEFIBRILLATORS MARKET FOR OTHER END USERS, BY REGION, 2018–2026 (USD MILLION) 98 9 DEFIBRILLATORS MARKET, BY REGION 99 9.1 INTRODUCTION 100 FIGURE 22 GEOGRAPHIC SNAPSHOT OF THE DEFIBRILLATORS MARKET 100 TABLE 44 DEFIBRILLATORS MARKET, BY REGION, 2018–2026 (USD MILLION) 100 9.2 NORTH AMERICA 101 FIGURE 23 NORTH AMERICA: DEFIBRILLATORS MARKET SNAPSHOT 101 TABLE 45 NORTH AMERICA: DEFIBRILLATORS MARKET, BY COUNTRY, 2018–2026 (USD MILLION) 102 TABLE 46 NORTH AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 102 TABLE 47 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 102 TABLE 48 NORTH AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 103 TABLE 49 NORTH AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 103 TABLE 50 NORTH AMERICA: DEFIBRILLATORS MARKET, BY END USER, 2018–2026 (USD MILLION) 104 TABLE 51 NORTH AMERICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 104 9.2.1 US 104 9.2.1.1 High adoption rate of AEDs in the country to drive market growth 104 TABLE 52 US: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 106 TABLE 53 US: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 106 TABLE 54 US: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 106 TABLE 55 US: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 107 9.2.2 CANADA 107 9.2.2.1 High burden of CVDs in the country contributes to the growth of the defibrillators market in Canada 107 TABLE 56 CANADA: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 108 TABLE 57 CANADA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 108 TABLE 58 CANADA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 108 TABLE 59 CANADA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 109 9.3 EUROPE 109 TABLE 60 EUROPE: DEFIBRILLATORS MARKET, BY COUNTRY, 2018–2026 (USD MILLION) 109 TABLE 61 EUROPE: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 110 TABLE 62 EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 110 TABLE 63 EUROPE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 110 TABLE 64 EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 111 TABLE 65 EUROPE: DEFIBRILLATORS MARKET, BY END USER, 2018–2026 (USD MILLION) 111 TABLE 66 EUROPE: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 112 9.3.1 GERMANY 112 9.3.1.1 Presence of non-profit organizations that provide defibrillator services in the country to drive market growth in Germany 112 TABLE 67 GERMANY: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 113 TABLE 68 GERMANY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 113 TABLE 69 GERMANY: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 113 TABLE 70 GERMANY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 114 9.3.2 UK 114 9.3.2.1 Rising support from government and private organizations and increasing awareness related to defibrillators are fueling market growth 114 TABLE 71 UK: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 115 TABLE 72 UK: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 115 TABLE 73 UK: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 115 TABLE 74 UK: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 116 9.3.3 FRANCE 116 9.3.3.1 Increasing prevalence of chronic diseases in the geriatric population—a key driver for market growth in France 116 TABLE 75 FRANCE: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 117 TABLE 76 FRANCE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 117 TABLE 77 FRANCE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 117 TABLE 78 FRANCE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 118 9.3.4 ITALY 118 9.3.4.1 High prevalence of OHCA in the country is driving the growth of the defibrillators market in Italy 118 TABLE 79 ITALY: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 118 TABLE 80 ITALY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 119 TABLE 81 ITALY: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 119 TABLE 82 ITALY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 119 9.3.5 SPAIN 120 9.3.5.1 Increasing number of conferences and awareness programs to support the growth of the defibrillators market in Spain 120 TABLE 83 SPAIN: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 120 TABLE 84 SPAIN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 120 TABLE 85 SPAIN: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 121 TABLE 86 SPAIN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 121 9.3.6 REST OF EUROPE 121 TABLE 87 ROE: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 122 TABLE 88 ROE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 122 TABLE 89 ROE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 122 TABLE 90 ROE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 123 9.4 ASIA PACIFIC 123 FIGURE 24 ASIA PACIFIC: DEFIBRILLATORS MARKET SNAPSHOT 124 TABLE 91 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY COUNTRY, 2018–2026 (USD MILLION) 125 TABLE 92 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 125 TABLE 93 ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 125 TABLE 94 ASIA PACIFIC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 126 TABLE 95 ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 126 TABLE 96 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY END USER, 2018–2026 (USD MILLION) 127 TABLE 97 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 127 9.4.1 JAPAN 127 9.4.1.1 Presence of a universal insurance scheme in Japan to support market growth 127 TABLE 98 JAPAN: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 128 TABLE 99 JAPAN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 128 TABLE 100 JAPAN: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 129 TABLE 101 JAPAN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 129 9.4.2 CHINA 129 9.4.2.1 Growing focus of market players on expanding their presence in China to drive market growth 129 TABLE 102 CHINA: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 130 TABLE 103 CHINA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 130 TABLE 104 CHINA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 131 TABLE 105 CHINA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 131 9.4.3 INDIA 131 9.4.3.1 High incidence and prevalence of CVDs in the country to drive market growth 131 TABLE 106 INDIA: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 132 TABLE 107 INDIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 132 TABLE 108 INDIA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 133 TABLE 109 INDIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 133 9.4.4 AUSTRALIA 133 9.4.4.1 Measures taken by government and private bodies to make AEDs available at public sites in the country to drive market growth 133 TABLE 110 AUSTRALIA: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 134 TABLE 111 AUSTRALIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 134 TABLE 112 AUSTRALIA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 134 TABLE 113 AUSTRALIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 135 9.4.5 SOUTH KOREA 135 9.4.5.1 Rising incidence of cardiac disorders to drive the growth of the defibrillators market in South Korea 135 TABLE 114 SOUTH KOREA: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 135 TABLE 115 SOUTH KOREA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 136 TABLE 116 SOUTH KOREA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 136 TABLE 117 SOUTH KOREA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 136 9.4.6 REST OF ASIA PACIFIC (ROAPAC) 137 TABLE 118 REST OF ASIA PACIFIC: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 137 TABLE 119 REST OF ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 138 TABLE 120 REST OF ASIA PACIFIC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 138 TABLE 121 REST OF ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 138 9.5 LATIN AMERICA 139 TABLE 122 LATIN AMERICA: DEFIBRILLATORS MARKET, BY COUNTRY, 2018–2026 (USD MILLION) 139 TABLE 123 LATIN AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 139 TABLE 124 LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 140 TABLE 125 LATIN AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 140 TABLE 126 LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 140 TABLE 127 LATIN AMERICA: DEFIBRILLATORS MARKET, BY END USER, 2018–2026 (USD MILLION) 141 TABLE 128 LATIN AMERICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 141 9.5.1 BRAZIL 141 9.5.1.1 Large obese population in the country results in an increased demand for defibrillators 141 TABLE 129 BRAZIL: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 142 TABLE 130 BRAZIL: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 142 TABLE 131 BRAZIL: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 142 TABLE 132 BRAZIL: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 143 9.5.2 MEXICO 143 9.5.2.1 High prevalence of target diseases in the country to drive the growth of the defibrillators market in Mexico 143 TABLE 133 MEXICO: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 143 TABLE 134 MEXICO: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 144 TABLE 135 MEXICO: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 144 TABLE 136 MEXICO: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 144 9.5.3 REST OF LATIN AMERICA 145 TABLE 137 REST OF LATIN AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 145 TABLE 138 REST OF LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 145 TABLE 139 REST OF LATIN AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 146 TABLE 140 REST OF LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 146 9.6 MIDDLE EAST & AFRICA 147 TABLE 141 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 147 TABLE 142 MIDDLE EAST & AFRICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 147 TABLE 143 MIDDLE EAST & AFRICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 148 TABLE 144 MIDDLE EAST & AFRICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2018–2026 (USD MILLION) 148 TABLE 145 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY END USER, 2018–2026 (USD MILLION) 149 TABLE 146 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 149 10 COMPETITIVE LANDSCAPE 150 10.1 INTRODUCTION 150 FIGURE 25 KEY DEVELOPMENTS BY LEADING PLAYERS IN THE DEFIBRILLATORS MARKET, 2018–2021 150 10.2 REVENUE SHARE ANALYSIS 151 FIGURE 26 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE DEFIBRILLATORS MARKET 151 10.3 MARKET SHARE ANALYSIS 152 FIGURE 27 DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER, 2020 152 TABLE 147 DEFIBRILLATOR MARKET: DEGREE OF COMPETITION 152 10.4 COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2020) 154 10.4.1 TERMINOLOGY/NOMENCLATURE 154 10.4.1.1 Stars 154 10.4.1.2 Emerging leaders 154 10.4.1.3 Pervasive players 154 10.4.1.4 Participants 154 FIGURE 28 DEFIBRILLATORS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020 155 10.5 COMPETITIVE LEADERSHIP MAPPING: START-UP/SME EVALUATION QUADRANT (AS OF 2020) 156 10.5.1 PROGRESSIVE COMPANIES 156 10.5.2 RESPONSIVE COMPANIES 156 10.5.3 DYNAMIC COMPANIES 156 10.5.4 STARTING BLOCKS 156 FIGURE 29 DEFIBRILLATORS MARKET: COMPETITIVE LEADERSHIP MAPPING (SMES/START-UPS) 157 10.6 COMPETITIVE BENCHMARKING 158 TABLE 148 PRODUCT FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE DEFIBRILLATORS MARKET 158 TABLE 149 END-USER FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE DEFIBRILLATOR MARKET 159 TABLE 150 COMPANY FOOTPRINT ANALYSIS IN THE DEFIBRILLATORS MARKET 160 10.7 COMPETITIVE SCENARIO (2018–2021) 161 10.7.1 NEW PRODUCT LAUNCHES & APPROVALS 161 10.7.2 DEALS 162 10.7.3 OTHER DEVELOPMENTS 162 11 COMPANY PROFILES 164 11.1 KEY PLAYERS 164 (Business overview, Products offered, Recent developments, MNM view)* 11.1.1 MEDTRONIC 164 TABLE 151 MEDTRONIC: BUSINESS OVERVIEW 164 FIGURE 30 MEDTRONIC PLC: COMPANY SNAPSHOT (2020) 165 11.1.2 STRYKER CORPORATION 169 TABLE 152 STRYKER CORPORATION: BUSINESS OVERVIEW 169 FIGURE 31 STRYKER CORPORATION: COMPANY SNAPSHOT (2020) 170 11.1.3 KONINKLIJKE PHILIPS N.V. 172 TABLE 153 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 172 FIGURE 32 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020) 173 11.1.4 ASAHI KASEI CORPORATION 176 TABLE 154 ASAHI KASEI CORPORATION: BUSINESS OVERVIEW 176 FIGURE 33 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2020) 177 11.1.5 BOSTON SCIENTIFIC CORPORATION 179 TABLE 155 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 179 FIGURE 34 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2020) 180 11.1.6 ABBOTT 183 TABLE 156 ABBOTT: BUSINESS OVERVIEW 183 FIGURE 35 ABBOTT: COMPANY SNAPSHOT (2020) 184 11.1.7 MICROPORT 186 TABLE 157 MICROPORT: BUSINESS OVERVIEW 186 FIGURE 36 MICROPORT: COMPANY SNAPSHOT (2020) 187 11.1.8 NIHON KOHDEN CORPORATION 189 TABLE 158 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW 189 FIGURE 37 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2020) 190 11.1.9 BIOTRONIK 192 TABLE 159 BIOTRONIK: BUSINESS OVERVIEW 192 11.1.10 CU MEDICAL SYSTEMS INC. 194 TABLE 160 CU MEDICAL SYSTEMS INC.: BUSINESS OVERVIEW 194 FIGURE 38 CU MEDICAL SYSTEMS INC.: COMPANY SNAPSHOT (2020) 194 11.1.11 METSIS MEDIKAL 196 TABLE 161 METSIS MEDIKAL: BUSINESS OVERVIEW 196 11.1.12 MEDIANA CO. LTD. 197 TABLE 162 MEDIANA CO. LTD.: BUSINESS OVERVIEW 197 FIGURE 39 MEDIANA CO. LTD.: COMPANY SNAPSHOT (2020) 197 11.1.13 MINDRAY MEDICAL INTERNATIONAL LIMITED 199 TABLE 163 MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW 199 FIGURE 40 MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2020) 200 11.1.14 PROGETTI SRL - MEDICAL EQUIPMENT SOLUTIONS 202 TABLE 164 PROGETTI SRL – MEDICAL EQUIPMENT SOLUTIONS: BUSINESS OVERVIEW 202 11.1.15 SCHILLER AG 203 TABLE 165 SCHILLER AG: BUSINESS OVERVIEW 203 11.2 OTHER PLAYERS 205 11.2.1 BPL MEDICAL TECHNOLOGIES 205 TABLE 166 BPL MEDICAL TECHNOLOGIES: BUSINESS OVERVIEW 205 11.2.2 METRAX GMBH (PRIMEDIC) 206 TABLE 167 METRAX GMBH (PRIMEDIC): BUSINESS OVERVIEW 206 11.2.3 MS WESTFALIA GMBH 207 TABLE 168 MS WESTFALIA GMBH: BUSINESS OVERVIEW 207 11.2.4 BEXEN CARDIO 208 TABLE 169 BEXEN CARDIO: BUSINESS OVERVIEW 208 11.2.5 AXION MEDICAL EQUIPMENT LTD. 210 TABLE 170 AXION MEDICAL EQUIPMENT LTD.: BUSINESS OVERVIEW 210 11.2.6 ELEMENT SCIENCE INC. 211 TABLE 171 ELEMENT SCIENCE INC.: BUSINESS OVERVIEW 211 11.2.7 AVIVE SOLUTIONS INC. 212 TABLE 172 AVIVE SOLUTIONS INC.: BUSINESS OVERVIEW 212 11.2.8 JEEVTRONICS PVT. LTD. 213 TABLE 173 JEEVTRONICS PVT. LTD.: BUSINESS OVERVIEW 213 11.2.9 HEARTHERO INC. 214 TABLE 174 HEARTHERO INC.: BUSINESS OVERVIEW 214 11.2.10 SHENZHEN COMEN MEDICAL INSTRUMENTS LTD. 215 TABLE 175 SHENZHEN COMEN MEDICAL INSTRUMENTS LTD.: BUSINESS OVERVIEW 215 *Business overview, Products offered, Recent developments, MNM view might not be captured in case of unlisted companies. 12 APPENDIX 216 12.1 DISCUSSION GUIDE 216 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 220 12.3 AVAILABLE CUSTOMIZATIONS 222 12.4 RELATED REPORTS 223 12.5 AUTHOR DETAILS 224
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(高度管理医療機器)の最新刊レポート
MarketsandMarkets 社の最新刊レポート
本レポートと同じKEY WORD(apac)の最新刊レポートよくあるご質問MarketsandMarkets社はどのような調査会社ですか?マーケッツアンドマーケッツ(MarketsandMarkets)は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/07/05 10:26 162.17 円 175.82 円 209.73 円 |